Ruby Hall Clinic is a prominent hospital in the city of Pune, India. It is a 750-bed hospital facility with a staff of 300 consultants, 650 panel doctors and 1500 paramedical staff and was accredited by National Accreditation Board for Hospitals & Healthcare Providers.

There are 750 beds in Ruby Hall Clinic.

During the past decade, Ruby Hall Clinic conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 37 clinical trials were completed, i.e. on average, 88.1% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 24 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ruby Hall Clinic" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Pfizer" with 6 trials sponsored, "United Therapeutics" with 6 trials sponsored and "Boehringer Ingelheim" with 6 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ruby Hall Clinic" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Merck Ltd., India" with 3 trials as a collaborator, "Academic GI Cancer Consortium (AGICC)" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Asian Clinical Trials" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Ruby Hall Clinic" are "Ulcerative Colitis" (9 trials), "Coronary Artery Disease" (4 trials), "Crohn's Disease" (4 trials), "Pulmonary Arterial Hypertension" (4 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Ruby Hall Clinic" in a lesser frequency.

Most popular intervention types in "Ruby Hall Clinic" are "Drug" (77 trials), "Biological" (7 trials), "Other" (4 trials), "Device" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Filgotinib" (4 trials), "Mirikizumab" (4 trials), "Etrasimod" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ruby Hall Clinic" are 83 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ruby Hall Clinic". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 60 completed trials in Ruby Hall Clinic, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Ruby Hall Clinic, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 2 trials that are defined as “Not Applicable".